Preimplantation
Genetic Testing
Preimplantation
Genetic Testing
Preimplantation Genetic Testing (PGT) is a groundbreaking technology that enhances the IVF process by screening embryos for chromosomal abnormalities and genetic conditions, increasing implantation success rates and reducing miscarriage risks. At Global Fertility & Genetics, we combine this advanced approach with personalized care to support informed decisions on your journey to parenthood.
What are the Benefits and Limitations of Preimplantation Genetic Testing (PGT)?
Preimplantation Genetic Testing (PGT) involves analyzing, selecting, and transferring embryos with the correct number of chromosomes. This advanced screening enhances implantation rates and reduces pregnancy losses by identifying the healthiest embryos before transfer. Women who carry chromosomal disorders, are over 35, or have experienced previous miscarriages are ideal candidates for PGT.
By selecting embryos with the proper chromosomal makeup, PGT helps prevent conditions such as aneuploidy and Down syndrome. Aneuploidy, a condition where an embryo has too many or too few chromosomes, accounts for over 60% of spontaneous miscarriages and is the most common reason for IVF failure. PGT enables the identification of the most viable embryos for transfer, reducing the need to transfer multiple embryos and minimizing the risk of multiple pregnancies.
The Benefits of PGT
The Benefits of PGT
- Improved Success Rates: PGT identifies embryos with the ideal chromosomal makeup, increasing implantation rates and reducing pregnancy losses.
- Reduced Risk of Genetic Disorders: Screening helps detect and avoid chromosomal abnormalities, such as Down syndrome and aneuploidy, ensuring healthier pregnancies.
- Targeted Embryo Selection: Selects the most viable embryos, reducing the need to transfer multiple embryos and minimizing the risk of multiple pregnancies.
- Ideal for High-Risk Patients: Women over 35, those with a history of miscarriages, or those carrying genetic conditions greatly benefit from PGT.
Limitations of PGT
Limitations of PGT
- No Guarantee of Pregnancy: While PGT improves odds, it does not ensure pregnancy.
- Embryo Impact: Testing is minimally invasive, performed with the utmost care by skilled professionals to protect embryo health.
- Cost Considerations: PGT adds to IVF costs, but financing options are often available to assist with affordability.
Who Should Consider PGT?
Who Should Consider PGT?
- Women with Recurrent Pregnancy Loss: PGT can help identify viable embryos, reducing miscarriage risks.
- Women Over 35: Older women benefit from targeted embryo selection to optimize IVF success.
- Couples with Genetic Conditions: Those with known chromosomal disorders or genetic concerns are ideal candidates.
- Individuals Seeking Family Balancing: PGT allows couples to plan for family balancing with precision.
How PGT Works
How PGT Works
- Embryo Biopsy: A small sample of cells is taken from embryos developed during IVF.
- Genetic Analysis: Samples are tested for chromosomal and genetic conditions to ensure viability.
- Embryo Selection: Healthy embryos are selected for transfer, optimizing the chances of a successful pregnancy.
Preimplantation Genetic Testing for Polygenic Risk
PGT-P stands for Preimplantation Genetic Testing for Polygenic Risk. It is an advanced genetic screening test for embryos that analyzes an embryo’s polygenic risk score (PRS) for common adult-onset diseases like certain cancers and cardiovascular disease. It is a probabilistic test, meaning it estimates a risk level, and is different from older PGT types that focus on single gene mutations or chromosomal abnormalities.
How PGT-P Works
How PGT-P Works
- Calculates a risk score: A PRS is calculated for the embryo for various conditions based on its genetic makeup.
- Uses a large genetic dataset: The analysis looks at many genetic variants and compares them to large populations to estimate the risk.
- Provides probabilistic results: The score is not a guarantee of getting or avoiding a disease, but rather an estimate of the embryo’s risk compared to the general population.
- Supplements other PGT tests: PGT-P can be used with other PGT tests, like PGT-A (aneuploidy) and PGT-M (monogenic disorders), to provide more comprehensive information about the embryo.
Key Differences from other PGT
Key Differences from other PGT
- Focus: PGT-P focuses on polygenic conditions (influenced by many genes and environmental factors), whereas PGT-M focuses on single-gene disorders.
- Result type: PGT-P provides a probabilistic risk score, while PGT-M can definitively identify if an embryo is impacted, unaffected, or a carrier for a specific disease.
- Complexity: It is a more complex test because it considers a broader spectrum of disease risk rather than a single, simple genetic issue.
Considerations and Limitations
Considerations & Limitatoins of PGT-P
- Environmental factors: PGT-P does not account for non-genetic factors like lifestyle, which can significantly influence the actual risk of developing a disease.
- Ethical questions: It raises ethical considerations regarding embryo selection, the potential for “designer babies,” and equal access to the technology.
- Regulatory status: The technology is still developing, and regulatory guidelines and scientific evidence are still evolving in many places. For example, it is currently not permitted in the UK.